Sign in

CIK 0001875091 · Non-accelerated filer<br>Emerging growth company

NeuroSense Therapeutics Ltd.

Sign in to watch
Ticker
NRSN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
other
Phone
972-9-9531142
Business address
11 HAMENOFIM ST., BUILDING B, HERZLIYA, Israel, 4672562

Securities

  • NRSN Ordinary Shares Nasdaq
  • NRSNW Warrant Nasdaq
  1. 6-K Event Report of Foreign Issuer
  2. 6-K Event Report of Foreign Issuer
  3. 6-K Event Report of Foreign Issuer
  4. 6-K Event Report of Foreign Issuer
  5. 6-K Event Report of Foreign Issuer
  6. 6-K Event Report of Foreign Issuer
  7. 6-K Event Report of Foreign Issuer
  8. 6-K Event Report of Foreign Issuer
  9. 6-K Event Report of Foreign Issuer
  10. 6-K Event Report of Foreign Issuer
  11. EFFECT Other Notice of Effectiveness
  12. 6-K Event Report of Foreign Issuer
  13. 6-K Event Report of Foreign Issuer
  14. F-3/A Offering F-3/A
  15. 6-K Event Report of Foreign Issuer
  16. 6-K Event Report of Foreign Issuer
  17. 6-K Event Report of Foreign Issuer
  18. 4 Open-market buy Chief Executive Officer bought 250,000 shares at $0.80 ($200,000)
  19. 4 Open-market buy Chief Financial Officer bought 250,000 shares at $0.80 ($200,000)
  20. 6-K Event Report of Foreign Issuer

Page 1 of 16 · 314 filings